Deal Details

Calibre Scientific Refinances Debt

Healthcare

Calibre Scientific, a business of StoneCalibre, debt recapitalization

Summary

Calibre Scientific, Inc. (“Calibre Scientific” or the “Company”), the life sciences and diagnostics business owned by StoneCalibre, LLC (“StoneCalibre”), recently completed a recapitalization through a $92 million multicurrency first lien facility. The Company intends to use the proceeds to refinance the existing debt facility and to support its global acquisition strategy.

Baird served as the exclusive debt advisor to Calibre Scientific, Inc. on this transaction.

About

Founded in 2013, Calibre Scientific is a diversified global developer, manufacturer and distributor of consumable products in the life sciences and diagnostics markets. Since inception, the business has continually expanded through a combination of organic growth and acquisitions, and today has a broad portfolio of more than 3,000 products, which it sells into over 100 countries worldwide. Calibre Scientific’s 6,000+ customers include blue-chip biopharmaceutical companies, leading academic institutions and diagnostics companies.

StoneCalibre is a privately funded investment firm specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. StoneCalibre is headquartered in Los Angeles, California.

Healthcare

Calibre Scientific, a business of StoneCalibre, debt recapitalization